The FDA pulls back another treatment that doesn't work against omicron, and the federal government warns that without more funding it'll run out of antibodies to give states. Jessica was a writer on ...

Doctors across the United States are relying more on monoclonal antibodies as a powerful weapon against COVID-19. The lab-grown proteins help the body target and eliminate a COVID infection. According ...

Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers federal public health agencies. For those who are especially vulnerable to severe COVID-19, providers ...

In the ongoing battle against COVID-19, the United States has leaned heavily on vaccines as its primary weapon. While vaccination has been a cornerstone of the country’s public health strategy, it's ...

Monoclonal antibodies target specific disease molecules. They can help treat cancer, autoimmune disorders, and infectious diseases. Discover what you should know about this therapy. Monoclonal ...

Monoclonal antibodies were approved as a COVID-19 treatment by the FDA last year, and again in February and May. This therapy works best for people who face severe complications from SARS-CoV-2—but it ...

The FDA issued an emergency use authorization (EUA) for pemivibart (Pemgarda) as COVID-19 pre-exposure prophylaxis in immunocompromised individuals who are unlikely to mount a sufficient immune ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Update, Jan. 14, 2022: Monoclonal antibody ...

For months, doctors have relied on monoclonal antibody treatments to help keep patients at high risk for severe COVID-19 out of the hospital. But the rapid rise of the Omicron variant is making that ...